Clinical Trial Update: A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing venetoclax plus azacitidine to standard of care after allogeneic stem cell transplantation in acute myeloid leukemia; the study has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclyxto (Venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia (AML), Cancer | Phase 3 | Status: TERMINATED